DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance

Melanoma MethylClasses may provide clinical value in predicting 5-year death from melanoma among patients with primary melanoma independent of other clinicopathologic factors.

Authors

Institutions

Publication Details

Journal
JCO Precision Oncology
Published
2024-11-01
DOI
https://doi.org/10.1200/po-24-00375
Citations
6
Primary Topic
Cutaneous Melanoma Detection and Management
Type
article
Field-Weighted Citation Impact
1.70

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance

Tawny W. Boyce, Paul B. Googe, Esperanza Manrique‐Silva, James S. Wilmott et al.
6 citations
JCO Precision Oncology
Cutaneous Melanoma Detection and Management
1.70
article

DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance

Tawny W. Boyce, Paul B. Googe, Esperanza Manrique‐Silva, James S. Wilmott, Eva Hernando, V. Través, Adam Z. Reynolds, Caroline E. Kostrzewa, Hazel Burke, Meg R. Gerstenblith, Peter Ngo, Dakai Zhu, David W. Ollila, Anne Elizabeth Cust, Kelli O’Connell, Michelle Rainka, Jeffrey E. Lee, Adriana Heguy, Klaus J. Busam, Christopher Ian Amos, Lan Lin, Keimya Sadeghi, Kathleen Conway, Anne S. Reiner, Douglas Hanniford, Gauri Panse, Venkatraman Seshan, Sitharam Ramaswami, Ivan Gorlov, Stergios J. Moschos, Howard Colman, Nancy E. Thomas, Shaofeng Yan, Amanda M. Vondras, Ismael A. Vergara, Honglin Hao, Pei Fen Kuan, Valerie Jakrot, Pauline Funchain, David L. Corcoran, Benjamin T. Fullerton, Siok Leong, Charles L. Wiggins, Marianne Berwick, Sheri L. Holmen, Peter M. Ferguson, Bonnie E. Gould Rothberg, Allison Reiner, Eduardo Nagore, Jessica M. Kenney, Irene Orlow, Heta Parmar, Judy R. Rees, Una Moran, Yi‐Hsuan Tsai, Paul N. Bogner, Natalie D. Depcik‐Smith, Celia Requena, Marcus Bosenberg, Yvonne M. Saenger, Colin B. Begg, Cheryl L. Thompson, Jennifer S. Ko, Cecilia Lezcano, Iman Osman, Eloise Parrish, Elise K. Brunsgaard, Arshi Arora, Richard A. Scolyer, Tim K. Lee, Sharon N. Edmiston, David Millán-Esteban, Graham J. Mann, Marc S. Ernstoff, Diana Argibay, Sergio Corrales, Li Luo, Lan Lin, Ping Shang, Ronglai Shen, David A. Wada, Gbemisola Ilelaboye, Gbemisola Elizabeth Ilelaboye
article en
6 citations

Abstract

Melanoma MethylClasses may provide clinical value in predicting 5-year death from melanoma among patients with primary melanoma independent of other clinicopathologic factors.

JCO Precision OncologyVol. 8(8)
University of North Carolina at Chapel Hill (US), Australian National University (AU), Rush University Medical Center (US), Dartmouth–Hitchcock Medical Center (US), BC Cancer Agency (CA), Roswell Park Comprehensive Cancer Center (US), The University of Sydney (AU), Albert Einstein College of Medicine (US), Cleveland Clinic (US), State University of New York (US), Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), University of Miami (US), Palo Alto University (US), University of Utah (US), Columbia University Irving Medical Center (US), Royal Prince Alfred Hospital (AU), Huntsman Cancer Institute (US), Valencia Catholic University Saint Vincent Martyr (ES), Yale University (US), Fundación Instituto Valenciano de Oncología (ES), Baylor School (US), Melanoma Institute Australia (AU), National Cancer Institute (US), UNM Comprehensive Cancer Center, New York University (US), Case Western Reserve University (US), Stony Brook University (US), Penn State Milton S. Hershey Medical Center (US), Cancer Council NSW (AU), Stanford University (US)
Pfizer, Melanoma Research Alliance, Memorial Sloan-Kettering Cancer Center, Char and Chuck Fowler Family Foundation, Huntsman Cancer Foundation, Melanoma Institute Australia, National Institutes of Health, University of Texas MD Anderson Cancer Center, University of North Carolina at Chapel Hill, Medical Research Council, National Health and Medical Research Council, National Cancer Institute, National Institute of Environmental Health Sciences
Good health and well-being
Openalex Percentile: Top 13%
Cutaneous Melanoma Detection and Management
1.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.